CU-Boulder's CIMB Taps Boulder Innovation Center for Commercialization Assistance | GenomeWeb

NEW YORK (GenomeWeb News) – The Boulder Innovation Center said last week that it has received an undisclosed amount of financial support from the Colorado Initiative in Molecular Biotechnology program at the University of Colorado, Boulder.

BIC will use the funding to expand its bioscience program by working with CIMB faculty to identify and help develop promising commercial applications related to inventions resulting from their research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.